Risk of Psychiatric Disorders Up for Children With T1DM

This article originally appeared here.
Share this content:
Risk of Psychiatric Disorders Up for Children With T1DM
Risk of Psychiatric Disorders Up for Children With T1DM

WEDNESDAY, Feb. 11, 2015 (HealthDay News) -- Children with type 1 diabetes have an increased risk of psychiatric disorders, especially in the six months after diagnosis, according to a study published online Feb. 3 in Diabetes Care.

Agnieszka Butwicka, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined the risk of psychiatric disorders among individuals born in Sweden between 1973 and 2009. Data were collected from 17,122 children with type 1 diabetes and their 18,847 healthy siblings. They were followed until they turned 18.

The researchers found that within six months after the onset of diabetes, the risk of psychiatric morbidity was increased three-fold in children with type 1 diabetes versus the general population; within the total observation period, the risk was doubled. There was an increased risk in suicide attempts (hazard ratio, 1.7) and in most categories of psychiatric disorders. In probands, there was a decrease in the risk of psychiatric disorders from a hazard ratio of 2.7 in the cohort born in 1973 to 1986 to a hazard ratio of 1.9 for those born from 1997 to 2009. Among siblings of patients with type 1 diabetes, the risk for any psychiatric disorder had an estimated hazard ratio of 1.1 (95 percent confidence interval, 1.0 to 1.1), with no increased risk seen in any specific category of disorders.

"The results support recommendations on comprehensive mental health surveillance in children with type 1 diabetes, especially in recently diagnosed children," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »